-
1
-
-
0036784878
-
A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients
-
Green F, Stewart A, Norton H. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002; 236:416-421.
-
(2002)
Ann. Surg.
, vol.236
, pp. 416-421
-
-
Green, F.1
Stewart, A.2
Norton, H.3
-
2
-
-
6944230093
-
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging
-
O'Connell JB, Maggard MA, Ko Cy. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96:1420-1425.
-
(2004)
J. Natl. Cancer Inst.
, vol.96
, pp. 1420-1425
-
-
O'Connell, J.B.1
Maggard, M.A.2
Ko, Cy.3
-
3
-
-
0028956045
-
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
-
Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995; 122:321-326.
-
(1995)
Ann. Intern. Med.
, vol.122
, pp. 321-326
-
-
Moertel, C.G.1
Fleming, T.R.2
Macdonald, J.S.3
-
4
-
-
0029644482
-
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
-
International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators
-
International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345:939-944.
-
(1995)
Lancet
, vol.345
, pp. 939-944
-
-
-
5
-
-
0032950293
-
Efficacy of adjuvant fluorouracil and folonic acid in B2 colon cancer
-
International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators
-
International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folonic acid in B2 colon cancer. J Clin Oncol 1999; 17:1356-1363.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 1356-1363
-
-
-
6
-
-
0034712536
-
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
-
Douillard JY, Cunningham D, Roth A, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355:1041-1047.
-
(2000)
Lancet
, vol.355
, pp. 1041-1047
-
-
Douillard, J.Y.1
Cunningham, D.2
Roth, A.3
-
7
-
-
0033874892
-
Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer
-
De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938-2947.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 2938-2947
-
-
De Gramont, A.1
Figer, A.2
Seymour, M.3
-
8
-
-
0032414932
-
Survival of colorectal cancer patients in Europe during the period 1978-1989
-
Gatta G, Faivre J, Capocaccia R, et al. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998; 34:2176-2183.
-
(1998)
Eur. J. Cancer
, vol.34
, pp. 2176-2183
-
-
Gatta, G.1
Faivre, J.2
Capocaccia, R.3
-
9
-
-
0033831989
-
Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer
-
Wright C, Drent OF, Barker M, et al. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg 2000; 87:1197-1202.
-
(2000)
Br J. Surg.
, vol.87
, pp. 1197-1202
-
-
Wright, C.1
Drent, O.F.2
Barker, M.3
-
10
-
-
0037379737
-
Characterization of sporadic colon cancer by pattern of genomic instability
-
Goel A, Arnold CN, Niedzwiecki D, et al. Characterization of sporadic colon cancer by pattern of genomic instability. Cancer Res 2003; 63:1608-1614.
-
(2003)
Cancer Res.
, vol.63
, pp. 1608-1614
-
-
Goel, A.1
Arnold, C.N.2
Niedzwiecki, D.3
-
11
-
-
0031982505
-
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high risk colon cancer
-
O'Connell MJ, Laurie JA, Kahn M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high risk colon cancer. J Clin Oncol 1998; 16:295-300.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 295-300
-
-
O'Connell, M.J.1
Laurie, J.A.2
Kahn, M.3
-
12
-
-
0034527075
-
Adjuvant chemotherapy for stage II colon cancer: The time has come
-
Mamounas EP. Adjuvant chemotherapy for stage II colon cancer: the time has come. Eur J Surg Oncol 2000; 26:725-729.
-
(2000)
Eur. J. Surg. Oncol.
, vol.26
, pp. 725-729
-
-
Mamounas, E.P.1
-
13
-
-
0034522246
-
Adjuvant chemotherapy for stage II (Dukes B) colon cancer too early for routine use
-
Wein A, Hahn EG, Merkel S, et al. Adjuvant chemotherapy for stage II (Dukes B) colon cancer too early for routine use. Eur J Surg Oncol 2000; 26:730-732.
-
(2000)
Eur. J. Surg. Oncol.
, vol.26
, pp. 730-732
-
-
Wein, A.1
Hahn, E.G.2
Merkel, S.3
-
14
-
-
0032949446
-
Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results of four National Surgical Adjuvant Breast and Bowel Project adjuvant studies
-
Mamounas E, Wieand S, Wolmark, N et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results of four National Surgical Adjuvant Breast and Bowel Project adjuvant studies. J Clin Oncol 1999; 17:349-360.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 349-360
-
-
Mamounas, E.1
Wieand, S.2
Wolmark, N.3
-
15
-
-
0031841282
-
For patients with Dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis
-
Chaplin S, Cerottini JP, Bosman FT, et al. For patients with Dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998; 83:666-672.
-
(1998)
Cancer
, vol.83
, pp. 666-672
-
-
Chaplin, S.1
Cerottini, J.P.2
Bosman, F.T.3
-
16
-
-
0035883421
-
High-risk groups of patients with stage II colon carcinoma
-
Merkel S, Wein A, Gunther K, et al. High-risk groups of patients with stage II colon carcinoma. Cancer 2001; 92:1435-1443.
-
(2001)
Cancer
, vol.92
, pp. 1435-1443
-
-
Merkel, S.1
Wein, A.2
Gunther, K.3
-
17
-
-
0035205821
-
Identifying patients with T3-T4 node negative colon cancer at high risk of recurrence
-
Burdy G, Panis Y, Alves A, et al. Identifying patients with T3-T4 node negative colon cancer at high risk of recurrence. Dis Colon Rectum 2001; 44:1682-1688.
-
(2001)
Dis. Colon Rectum
, vol.44
, pp. 1682-1688
-
-
Burdy, G.1
Panis, Y.2
Alves, A.3
-
18
-
-
0029087223
-
Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients
-
Newland RC, Drent OF, Chapuis PH, et al. Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients. Cancer 1995; 76:564-571.
-
(1995)
Cancer
, vol.76
, pp. 564-571
-
-
Newland, R.C.1
Drent, O.F.2
Chapuis, P.H.3
-
19
-
-
0037994269
-
Nodal staging of colorectal carcinomas and sentinel nodes: Review
-
Cserni G. Nodal staging of colorectal carcinomas and sentinel nodes: Review. J Clin Pathol 2003; 56:327-335.
-
(2003)
J. Clin. Pathol.
, vol.56
, pp. 327-335
-
-
Cserni, G.1
-
20
-
-
0037322071
-
Survival after curative resection for mucinous adenocarcinoma of the colorectum
-
Kanemitsu Y, Kato T, Hirai T, et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 2003; 46:160-167.
-
(2003)
Dis. Colon Rectum
, vol.46
, pp. 160-167
-
-
Kanemitsu, Y.1
Kato, T.2
Hirai, T.3
-
21
-
-
0033462150
-
Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: Study matched for age, gender, grade, and stage
-
Psathakis D, Schiedeck TH, Krug F, et al. Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade, and stage. Dis Colon Rectum 1999; 42:1618-1625.
-
(1999)
Dis. Colon Rectum
, vol.42
, pp. 1618-1625
-
-
Psathakis, D.1
Schiedeck, T.H.2
Krug, F.3
-
22
-
-
0035046711
-
Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer
-
Grabowski P, Schindler I, Anagnostopoulos I, et al. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol 2001 13:405-411.
-
(2001)
Eur. J. Gastroenterol. Hepatol.
, vol.13
, pp. 405-411
-
-
Grabowski, P.1
Schindler, I.2
Anagnostopoulos, I.3
-
23
-
-
0037393449
-
Colorectal carcinoma: Diagnostic, prognostic, and molecular features: Review
-
Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features: review. Mod Pathol 2003; 16:376-388.
-
(2003)
Mod. Pathol.
, vol.16
, pp. 376-388
-
-
Compton, C.C.1
-
24
-
-
0025312728
-
A genetic model for colorectal tumorigenesis
-
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
-
(1990)
Cell
, vol.61
, pp. 759-767
-
-
Fearon, E.R.1
Vogelstein, B.2
-
25
-
-
0023748414
-
Genetic alterations during colorectal- tumor development
-
Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal- tumor development. N Engl J Med 1988; 319:525-532.
-
(1988)
N. Engl. J. Med.
, vol.319
, pp. 525-532
-
-
Vogelstein, B.1
Fearon, E.R.2
Hamilton, S.R.3
-
27
-
-
0033946516
-
Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGFbRII, BAX, HMSH3, HMSH6, IGFIIR and BLM genes
-
Calin GA, Gafa R, Tibiletti MG, et al. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGFbRII, BAX, HMSH3, HMSH6, IGFIIR and BLM genes. Int J Cancer 2000; 89:230-235.
-
(2000)
Int. J. Cancer
, vol.89
, pp. 230-235
-
-
Calin, G.A.1
Gafa, R.2
Tibiletti, M.G.3
-
28
-
-
7144256236
-
Morphology of sporadic colorectal cancer with DNA replication errors
-
Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998; 42:673-679.
-
(1998)
Gut
, vol.42
, pp. 673-679
-
-
Jass, J.R.1
Do, K.A.2
Simms, L.A.3
-
29
-
-
0032534069
-
National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
-
Boland CR, Thibodeau SN, Hamilton SR, et al. National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
-
(1998)
Cancer Res.
, vol.58
, pp. 5248-5257
-
-
Boland, C.R.1
Thibodeau, S.N.2
Hamilton, S.R.3
-
30
-
-
0034997971
-
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer
-
Ward R, Meagher A, Tomlison L et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001; 48:821-829.
-
(2001)
Gut
, vol.48
, pp. 821-829
-
-
Ward, R.1
Meagher, A.2
Tomlison, L.3
-
31
-
-
0031710654
-
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences
-
Fujiwara T, Stolker JM, Watanabe T, et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998; 153:1063-1078.
-
(1998)
Am. J. Pathol.
, vol.153
, pp. 1063-1078
-
-
Fujiwara, T.1
Stolker, J.M.2
Watanabe, T.3
-
32
-
-
0010945939
-
APC mutations in colorectal tumors with mismatch repair deficiency
-
Huang J, Papadopolos N, McKinley A, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 1996; 93: 9049-9054.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 9049-9054
-
-
Huang, J.1
Papadopolos, N.2
McKinley, A.3
-
33
-
-
0035185894
-
Features of colorectal cancers with high level microsatellite instability occurring in familial and sporadic settings parallel pathways of tumorigenesis
-
Young J, Simms LA, Biden KG, et al. Features of colorectal cancers with high level microsatellite instability occurring in familial and sporadic settings parallel pathways of tumorigenesis. Am J Pathol 2001; 159:2107-2116.
-
(2001)
Am. J. Pathol.
, vol.159
, pp. 2107-2116
-
-
Young, J.1
Simms, L.A.2
Biden, K.G.3
-
34
-
-
0041411494
-
Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer
-
Nash GM, Gimbel M, Shia J, et al. Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer. J Clin Oncol 2003; 21:3105-3112.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 3105-3112
-
-
Nash, G.M.1
Gimbel, M.2
Shia, J.3
-
35
-
-
0032836347
-
Colorectal cancer with and without microsatellite instability involves different genes
-
Salahshor S, Kressner U, Pahlman L, et al. Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer 1999; 26:247-252.
-
(1999)
Genes Chromosomes Cancer
, vol.26
, pp. 247-252
-
-
Salahshor, S.1
Kressner, U.2
Pahlman, L.3
-
36
-
-
0029991682
-
Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer
-
Bubb VJ, Curtis LJ, Cunningham C, et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 1996; 12:2641-2649.
-
(1996)
Oncogene
, vol.12
, pp. 2641-2649
-
-
Bubb, V.J.1
Curtis, L.J.2
Cunningham, C.3
-
37
-
-
0032892831
-
Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis
-
Feeley KM, Fullard JF, Heneghan MA, et al. Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis. J Pathol 1999; 188:14-17.
-
(1999)
J. Pathol.
, vol.188
, pp. 14-17
-
-
Feeley, K.M.1
Fullard, J.F.2
Heneghan, M.A.3
-
38
-
-
0036161851
-
Differential involvement of hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability
-
Yamamoto H, Min Y, Itoh F, et al. Differential involvement of hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosomes Cancer 2002; 33:322-325.
-
(2002)
Genes Chromosomes Cancer
, vol.33
, pp. 322-325
-
-
Yamamoto, H.1
Min, Y.2
Itoh, F.3
-
39
-
-
0142106934
-
Clinical significance of early-onset sporadic colorectal cancer with microsatellite instability
-
Jass JR. Clinical significance of early-onset sporadic colorectal cancer with microsatellite instability. Dis Colon Rectum 2003; 46:1305-1309.
-
(2003)
Dis. Colon Rectum
, vol.46
, pp. 1305-1309
-
-
Jass, J.R.1
-
40
-
-
0029066689
-
Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability
-
Markowitz SS, Wang J, Myeroff L, et al. Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 1995; 268:1336-1338.
-
(1995)
Science
, vol.268
, pp. 1336-1338
-
-
Markowitz, S.S.1
Wang, J.2
Myeroff, L.3
-
41
-
-
16144368515
-
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumors
-
Souza RF, Appel R, Yin J, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumors. Nat Genet 1996; 14:255-257.
-
(1996)
Nat. Genet.
, vol.14
, pp. 255-257
-
-
Souza, R.F.1
Appel, R.2
Yin, J.3
-
43
-
-
0035283097
-
Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers
-
Duval A, Rolland S, Compaint A, et al. Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum Mol Genet 2001; 10:513-518.
-
(2001)
Hum. Mol. Genet.
, vol.10
, pp. 513-518
-
-
Duval, A.1
Rolland, S.2
Compaint, A.3
-
44
-
-
0033599013
-
Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency
-
Bader S, Walker M, Hendrich B, et al. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 1999; 18:8044-8047.
-
(1999)
Oncogene
, vol.18
, pp. 8044-8047
-
-
Bader, S.1
Walker, M.2
Hendrich, B.3
-
45
-
-
0032743063
-
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability
-
Riccio A, Aaltonen LA, Godwin AK, et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 1999; 23:266-268.
-
(1999)
Nat. Genet.
, vol.23
, pp. 266-268
-
-
Riccio, A.1
Aaltonen, L.A.2
Godwin, A.K.3
-
46
-
-
0032859695
-
CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
-
Bertoni F, Codegoni AM, Furlan D, et al. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes Chromosomes Cancer 1999; 26:176-180.
-
(1999)
Genes Chromosomes Cancer
, vol.26
, pp. 176-180
-
-
Bertoni, F.1
Codegoni, A.M.2
Furlan, D.3
-
47
-
-
12944281108
-
Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
-
Chadwick RB, Jiang GL, Bennington GA, et al. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci U S A 2000; 97:2662-2667.
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 2662-2667
-
-
Chadwick, R.B.1
Jiang, G.L.2
Bennington, G.A.3
-
48
-
-
0034283031
-
Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability
-
Piao Z, Fang W, Malkhosyan S, et al. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 2000; 60:4701-4704.
-
(2000)
Cancer Res.
, vol.60
, pp. 4701-4704
-
-
Piao, Z.1
Fang, W.2
Malkhosyan, S.3
-
49
-
-
0033984095
-
Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis
-
Guanti G, Resta N, Simone C, et al. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet 2000; 22:283-287.
-
(2000)
Hum. Mol. Genet.
, vol.22
, pp. 283-287
-
-
Guanti, G.1
Resta, N.2
Simone, C.3
-
50
-
-
0344417114
-
Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype
-
Schwartz S, Yamamoto H, Navarro M, et al. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999; 59:2995-3002.
-
(1999)
Cancer Res.
, vol.59
, pp. 2995-3002
-
-
Schwartz, S.1
Yamamoto, H.2
Navarro, M.3
-
51
-
-
0034055156
-
Frameshift mutation in Fas, Apaf-1 and Bcl-10 in gastrointestinal cancer of the microsatellite mutator phenotype
-
Yamamoto H, Gil J, Schwartz S, et al. Frameshift mutation in Fas, Apaf-1 and Bcl-10 in gastrointestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 2000; 7:238-239.
-
(2000)
Cell Death Differ.
, vol.7
, pp. 238-239
-
-
Yamamoto, H.1
Gil, J.2
Schwartz, S.3
-
52
-
-
0033198994
-
Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability
-
Duval A, Gayet J, Zhou XP, et al. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 1999; 59:4213-4215.
-
(1999)
Cancer Res.
, vol.59
, pp. 4213-4215
-
-
Duval, A.1
Gayet, J.2
Zhou, X.P.3
-
53
-
-
0031018674
-
Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
-
Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997; 275:967-969.
-
(1997)
Science
, vol.275
, pp. 967-969
-
-
Rampino, N.1
Yamamoto, H.2
Ionov, Y.3
-
54
-
-
0141425677
-
Chromosomal imbalances in the colorectal carcinomas with microsatellite instability
-
Li LS, Kim NG, Kim SH, et al. Chromosomal imbalances in the colorectal carcinomas with microsatellite instability. Am J Pathol 2003; 163:1429-1436.
-
(2003)
Am. J. Pathol.
, vol.163
, pp. 1429-1436
-
-
Li, L.S.1
Kim, N.G.2
Kim, S.H.3
-
56
-
-
84898693543
-
Molecular characteristics of stage III colorectal cancer
-
(Abstract #6375)
-
Plukker JT, Westra JL, Hofstra R, et al. Molecular characteristics of stage III colorectal cancer. Proc Am Assoc Cancer Res 2003; 44:1460 (Abstract #6375).
-
(2003)
Proc. Am. Assoc. Cancer Res.
, vol.44
, pp. 1460
-
-
Plukker, J.T.1
Westra, J.L.2
Hofstra, R.3
-
57
-
-
0025848680
-
The International Collaborative Group on Hereditary Nonpolyposis colorectal cancer
-
Vasen HFA, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Nonpolyposis colorectal cancer. Dis Colon Rectum 1991; 34:424-425.
-
(1991)
Dis. Colon Rectum
, vol.34
, pp. 424-425
-
-
Vasen, H.F.A.1
Mecklin, J.P.2
Khan, P.M.3
-
59
-
-
0034692454
-
Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases
-
Peel DJ, Ziogas A, Fox EA, et al. Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2000; 92:1517-1522.
-
(2000)
J. Natl. Cancer Inst.
, vol.92
, pp. 1517-1522
-
-
Peel, D.J.1
Ziogas, A.2
Fox, E.A.3
-
60
-
-
0027742295
-
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
-
Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75:1027-1038.
-
(1993)
Cell
, vol.75
, pp. 1027-1038
-
-
Fishel, R.1
Lescoe, M.K.2
Rao, M.R.3
-
61
-
-
0027933070
-
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
-
Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371:75-80.
-
(1994)
Nature
, vol.371
, pp. 75-80
-
-
Nicolaides, N.C.1
Papadopoulos, N.2
Liu, B.3
-
62
-
-
0028308161
-
Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers
-
Horii A, Han HJ, Shimada M, et al. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res 1994; 543:3373-3375.
-
(1994)
Cancer Res.
, vol.543
, pp. 3373-3375
-
-
Horii, A.1
Han, H.J.2
Shimada, M.3
-
63
-
-
0030882381
-
Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study
-
The International collaborative Group on Hereditary Nonpolyposis Colorectal Cancer
-
Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113:1146-1158.
-
(1997)
Gastroenterology
, vol.113
, pp. 1146-1158
-
-
Peltomaki, P.1
Vasen, H.F.2
-
64
-
-
2942569549
-
Analysis of mismatch repair genes in hereditary non-pollyposis colorectal cancer patients
-
Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-pollyposis colorectal cancer patients. Nat Med 1996; 2:169-74.
-
(1996)
Nat. Med.
, vol.2
, pp. 169-174
-
-
Liu, B.1
Parsons, R.2
Papadopoulos, N.3
-
65
-
-
0032554977
-
Identifying hereditary nonpolyposis colorectal cancer
-
Lynch HT, Smyrk TC. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 1998; 338:1537-1538.
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 1537-1538
-
-
Lynch, H.T.1
Smyrk, T.C.2
-
66
-
-
0030592517
-
Lessons from hereditary colorectal cancer
-
Kinzler KW, Vogelstein B. lessons from hereditary colorectal cancer. Cell 1996; 87:159-170.
-
(1996)
Cell
, vol.87
, pp. 159-170
-
-
Kinzler, K.W.1
Vogelstein, B.2
-
67
-
-
0035070046
-
Mutations in the APC tumour suppressor gene cause chromosomal instability
-
Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001; 3:433-438.
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 433-438
-
-
Fodde, R.1
Kuipers, J.2
Rosenberg, C.3
-
68
-
-
0035067391
-
A role for the adenomatous polyposis coli protein in chromosomal segregation
-
Kaplan KB, Burds AA, Swedlow JR, et al. A role for the adenomatous polyposis coli protein in chromosomal segregation. Nat Cell Biol 2001; 3:429-432.
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 429-432
-
-
Kaplan, K.B.1
Burds, A.A.2
Swedlow, J.R.3
-
70
-
-
0032514366
-
Chromosome number and structure both are markedly stable in RER colorectal cancer and are not destabilized by mutation of p53
-
Eshleman J, Casey G, Kochera M, et al. Chromosome number and structure both are markedly stable in RER colorectal cancer and are not destabilized by mutation of p53. Oncogene 1998; 17:719-725.
-
(1998)
Oncogene
, vol.17
, pp. 719-725
-
-
Eshleman, J.1
Casey, G.2
Kochera, M.3
-
71
-
-
0030895256
-
Overview of the epidemiology of colorectal cancer
-
Wilmink AB. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997; 40:483-493.
-
(1997)
Dis. Colon Rectum
, vol.40
, pp. 483-493
-
-
Wilmink, A.B.1
-
73
-
-
0034669608
-
Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability
-
Gafa R, Maestri L, Matteuzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer 2000; 89:2025-2037.
-
(2000)
Cancer
, vol.89
, pp. 2025-2037
-
-
Gafa, R.1
Maestri, L.2
Matteuzzi, M.3
-
74
-
-
0027136828
-
Genomic instability in colorectal cancer: Relationship to clinicopathologic variables and family history
-
Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathologic variables and family history. Cancer Res 1993; 53:5849-5852.
-
(1993)
Cancer Res.
, vol.53
, pp. 5849-5852
-
-
Lothe, R.A.1
Peltomaki, P.2
Meling, G.I.3
-
75
-
-
0033778049
-
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer recieving chemotherapy
-
Hemminki A, Mecklin JP, Jarvinen H, et al. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer recieving chemotherapy. Gastroenterology 2000; 119:921-928.
-
(2000)
Gastroenterology
, vol.119
, pp. 921-928
-
-
Hemminki, A.1
Mecklin, J.P.2
Jarvinen, H.3
-
76
-
-
0034642605
-
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
-
Gryfe R, Kim H, Hsieh ETK, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342:69-77.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 69-77
-
-
Gryfe, R.1
Kim, H.2
Hsieh, E.T.K.3
-
77
-
-
0031750404
-
Prognostic significance of allelic loss at chromosome 18q21 for stage II in colorectal. cancer
-
Carethers JM, Hawn JK, Greenson KJ, et al. Prognostic significance of allelic loss at chromosome 18q21 for stage II in colorectal. cancer. Gastroenterology 1998; 114:1188-1195.
-
(1998)
Gastroenterology
, vol.114
, pp. 1188-1195
-
-
Carethers, J.M.1
Hawn, J.K.2
Greenson, K.J.3
-
78
-
-
0035912144
-
Molecular predictors of survival after adjuvant chemotherapy for colon cancer
-
Watanabe T, Wu TT, Catalano PL, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001; 344:1196-1206.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1196-1206
-
-
Watanabe, T.1
Wu, T.T.2
Catalano, P.L.3
-
79
-
-
0034895979
-
P53 alterations and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma
-
Elsaleh H, Powell B, McCaul K, et al. P53 alterations and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 2001; 7:1343-1349.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 1343-1349
-
-
Elsaleh, H.1
Powell, B.2
McCaul, K.3
-
80
-
-
0033523204
-
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
-
Halling KC, French AJ, McDonnell SK, et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999; 91:1295-1303.
-
(1999)
J. Natl. Cancer Inst.
, vol.91
, pp. 1295-1303
-
-
Halling, K.C.1
French, A.J.2
McDonnell, S.K.3
-
81
-
-
0034690610
-
Association of tumor site and sex with survival benefit from adjuvant chemotherapy on colorectal cancer
-
Elsaleh H, Joseph D, Grieu F, et al. Association of tumor site and sex with survival benefit from adjuvant chemotherapy on colorectal cancer. Lancet 2000; 355:1745-1750.
-
(2000)
Lancet
, vol.355
, pp. 1745-1750
-
-
Elsaleh, H.1
Joseph, D.2
Grieu, F.3
-
82
-
-
0033986545
-
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: Impact on survival of 388 patients with Dukes' C colon carcinoma
-
Elsaleh H, Powell B, Soontrapornchai P, et al. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma. Oncology 2000; 58:52-59.
-
(2000)
Oncology
, vol.58
, pp. 52-59
-
-
Elsaleh, H.1
Powell, B.2
Soontrapornchai, P.3
-
83
-
-
0034852772
-
Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at population level
-
Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at population level. Cancer Epidemiol Biomarkers Prev 2001; 10:917-923.
-
(2001)
Cancer Epidemiol. Biomarkers Prev.
, vol.10
, pp. 917-923
-
-
Samowitz, W.S.1
Curtin, K.2
Ma, K.N.3
-
84
-
-
0038002279
-
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
-
Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349:247-257.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 247-257
-
-
Ribic, C.M.1
Sargent, D.J.2
Moore, M.J.3
-
85
-
-
0035418619
-
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells
-
Jacob S, Aguado M, Afallik D, et al. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res 2001; 61:6555-6562.
-
(2001)
Cancer Res.
, vol.61
, pp. 6555-6562
-
-
Jacob, S.1
Aguado, M.2
Afallik, D.3
-
86
-
-
0023262990
-
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
-
Forrester K, Almoguera C, Han K, et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327:298-303.
-
(1987)
Nature
, vol.327
, pp. 298-303
-
-
Forrester, K.1
Almoguera, C.2
Han, K.3
-
87
-
-
0031811341
-
Somatic mutations, acetylator status, and prognosis in colorectal cancer
-
Hardingdam JE, Butler WJ, Roder D. Somatic mutations, acetylator status, and prognosis in colorectal cancer. Gut 1998; 42:669-672.
-
(1998)
Gut
, vol.42
, pp. 669-672
-
-
Hardingdam, J.E.1
Butler, W.J.2
Roder, D.3
-
88
-
-
0032490124
-
Kirsten ras mutations in patients with colorectal cancer: A multicenter "Rascal" study
-
Andreyev HJ, Norman AR, Cunningham D, et al. Kirsten ras mutations in patients with colorectal cancer: a multicenter " Rascal" study. J Natl Cancer Inst 1998; 90:675-684.
-
(1998)
J. Natl. Cancer Inst.
, vol.90
, pp. 675-684
-
-
Andreyev, H.J.1
Norman, A.R.2
Cunningham, D.3
-
89
-
-
0032948553
-
p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer
-
Tortola S, Marcuello E, Gonzalez I, et al. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer. J Clin Oncol 1999; 17:1375-1381.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 1375-1381
-
-
Tortola, S.1
Marcuello, E.2
Gonzalez, I.3
-
90
-
-
0032521205
-
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group Study
-
Ahnen DJ, Feigl P, Quan G, et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group Study. Cancer Res 1998; 58:1149-1158.
-
(1998)
Cancer Res.
, vol.58
, pp. 1149-1158
-
-
Ahnen, D.J.1
Feigl, P.2
Quan, G.3
-
91
-
-
0035863495
-
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
-
Esteller M, Gonzalez S, Risques RA, et al. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J Clin Oncol 2001; 19:299-304.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 299-304
-
-
Esteller, M.1
Gonzalez, S.2
Risques, R.A.3
-
92
-
-
0035444798
-
Kirsten ras mutations in patients with colorectal cancer: The RASCAL II study
-
Andreyev HJ, Norman AR, Cunningham D, et al. Kirsten ras mutations in patients with colorectal cancer: The RASCAL II study. Br J Cancer 2001; 85:692-696.
-
(2001)
Br. J. Cancer
, vol.85
, pp. 692-696
-
-
Andreyev, H.J.1
Norman, A.R.2
Cunningham, D.3
-
93
-
-
0035059910
-
Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer
-
Font A, Abad A, Monzo M, et al. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum 2001; 44:549-557.
-
(2001)
Dis. Colon Rectum
, vol.44
, pp. 549-557
-
-
Font, A.1
Abad, A.2
Monzo, M.3
-
94
-
-
0028321495
-
Allelic loss of chromosome 18q and prognosis in colorectal cancer
-
Jen J, Kin J, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994; 331:213-221.
-
(1994)
N. Engl. J. Med.
, vol.331
, pp. 213-221
-
-
Jen, J.1
Kin, J.2
Piantadosi, S.3
-
95
-
-
0031827793
-
Chromosome 18q allelic loss and prognosis in stage II and stage III colon cancer
-
Lanza G, Mateuzzi M, Gafa R, et al. Chromosome 18q allelic loss and prognosis in stage II and stage III colon cancer. Int J Cancer 1998; 79:390-395.
-
(1998)
Int. J. Cancer
, vol.79
, pp. 390-395
-
-
Lanza, G.1
Mateuzzi, M.2
Gafa, R.3
-
96
-
-
0003119527
-
Confirmation that chromosome 18q allelic loss in colon cancer: A prognostic indicator
-
Ogunbiyi OA, Goodfellow PJ, Herfarth K, et al. Confirmation that chromosome 18q allelic loss in colon cancer: a prognostic indicator. J Clin Oncol 1998; 16:427-433.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 427-433
-
-
Ogunbiyi, O.A.1
Goodfellow, P.J.2
Herfarth, K.3
-
97
-
-
0033002320
-
Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
-
Jernvall P, Makinen MJ, Karttunen TJ, et al. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J Cancer 1999; 79:903-908.
-
(1999)
Br. J. Cancer
, vol.79
, pp. 903-908
-
-
Jernvall, P.1
Makinen, M.J.2
Karttunen, T.J.3
-
98
-
-
0037010411
-
Adjuvant x-ray and fluorouracil infusion study. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study
-
UKCCCR AXIS trial collaborators
-
Barratt PL, Seymour MT, Stenning SP, et al. UKCCCR AXIS trial collaborators. Adjuvant x-ray and fluorouracil infusion study. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet 2002; 360:1381-1391.
-
(2002)
Lancet
, vol.360
, pp. 1381-1391
-
-
Barratt, P.L.1
Seymour, M.T.2
Stenning, S.P.3
-
99
-
-
0035992401
-
Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival
-
Choi SW, Lee KJ, Bae Y, et al. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002; 8:2311-2322.
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 2311-2322
-
-
Choi, S.W.1
Lee, K.J.2
Bae, Y.3
-
100
-
-
0037364659
-
Genetic tumor markers with prognostic impact in Dukes' stage B and C colorectal cancer patients
-
Diep CB, Thorstensen L, Meling GI, et al. Genetic tumor markers with prognostic impact in Dukes' stage B and C colorectal cancer patients. J Clin Oncol 2003; 21:820-829.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 820-829
-
-
Diep, C.B.1
Thorstensen, L.2
Meling, G.I.3
-
101
-
-
0028596162
-
The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival
-
Dix BR, Robbins P, Soong R, et al. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 1994; 59:747-751.
-
(1994)
Int. J. Cancer
, vol.59
, pp. 747-751
-
-
Dix, B.R.1
Robbins, P.2
Soong, R.3
-
102
-
-
0030753698
-
p53 alterations are associated with improved prognosis in distal colonic carcinomas
-
Soong R, Grieu F, Robbins P, et al. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res 1997; 3:1405-1411.
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 1405-1411
-
-
Soong, R.1
Grieu, F.2
Robbins, P.3
-
103
-
-
0033815352
-
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumor site, stage, adjuvant chemotherapy and type of mutation
-
Soong R, Powell B, Elsaleh H, et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumor site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer 2000; 36:2053-2060.
-
(2000)
Eur. J. Cancer
, vol.36
, pp. 2053-2060
-
-
Soong, R.1
Powell, B.2
Elsaleh, H.3
-
104
-
-
0033192444
-
p53 point mutation and survival in colorectal cancer patients: Effect of disease dissemination and tumour location
-
Goh HS, Elnatan J, Low CH, et al. p53 point mutation and survival in colorectal cancer patients: effect of disease dissemination and tumour location. Int J Oncol 1999; 15:491-498.
-
(1999)
Int. J. Oncol.
, vol.15
, pp. 491-498
-
-
Goh, H.S.1
Elnatan, J.2
Low, C.H.3
-
105
-
-
0030934802
-
Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma
-
Pricolo VE, Finkelstein SD, Hansen K, et al. Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 1997; 132:371-374.
-
(1997)
Arch. Surg.
, vol.132
, pp. 371-374
-
-
Pricolo, V.E.1
Finkelstein, S.D.2
Hansen, K.3
-
106
-
-
0034103928
-
Molecular interactions in the Vogelstein model of colorectal carcinoma
-
Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 2000; 190:412-416.
-
(2000)
J. Pathol.
, vol.190
, pp. 412-416
-
-
Arends, J.W.1
-
107
-
-
0033015211
-
Prognostic value of p53 genetic changes in colorectal cancer
-
Kressner U, Inganas M, Byding S, et al. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol 1999; 17:593-599.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 593-599
-
-
Kressner, U.1
Inganas, M.2
Byding, S.3
-
108
-
-
0030037868
-
Clinical and pathological associations with p53 tumour suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma
-
Slebos RJC, Baas IO, Clement M, et al. Clinical and pathological associations with p53 tumour suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996; 74:165-171.
-
(1996)
Br. J. Cancer
, vol.74
, pp. 165-171
-
-
Slebos, R.J.C.1
Baas, I.O.2
Clement, M.3
-
109
-
-
0030035991
-
Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas
-
Smith DR, Ji CY, Gob HS. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 1996; 74:216-223.
-
(1996)
Br. J. Cancer
, vol.74
, pp. 216-223
-
-
Smith, D.R.1
Ji, C.Y.2
Gob, H.S.3
-
110
-
-
0032920520
-
Tomour markers of prognosis in colorectal cancer
-
McLeod HL, Murray GI. Tomour markers of prognosis in colorectal cancer. Br J Cancer 1999; 79:191-203.
-
(1999)
Br. J. Cancer
, vol.79
, pp. 191-203
-
-
McLeod, H.L.1
Murray, G.I.2
-
111
-
-
0035105560
-
The results of colorectal cancer treatment by p53 status: Treatment-specific overview
-
Petersen S, Thames HD, Nieder C, et al. The results of colorectal cancer treatment by p53 status: treatment-specific overview. Dis Colon Rectum 2001; 44:322-333.
-
(2001)
Dis. Colon Rectum
, vol.44
, pp. 322-333
-
-
Petersen, S.1
Thames, H.D.2
Nieder, C.3
-
112
-
-
0026546190
-
Survival and and aquired genetic alterations in colorectal cancer
-
Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and and aquired genetic alterations in colorectal cancer. Gastroenterology 1992; 102:1136-1141.
-
(1992)
Gastroenterology
, vol.102
, pp. 1136-1141
-
-
Laurent-Puig, P.1
Olschwang, S.2
Delattre, O.3
-
113
-
-
0033400036
-
Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer
-
Massa MJ, Iniesta P, Gonzalez-Quevedo R, et al. Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer. Eur J Cancer 1999; 35:1676-1682.
-
(1999)
Eur. J. Cancer
, vol.35
, pp. 1676-1682
-
-
Massa, M.J.1
Iniesta, P.2
Gonzalez-Quevedo, R.3
-
114
-
-
0028293408
-
Molecular genetics for clinical management of colorectal carcinoma. 17 p,18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential
-
Iino H, Fukayama M, Maeda Y, et al. Molecular genetics for clinical management of colorectal carcinoma. 17 p,18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994; 73:1324-1331.
-
(1994)
Cancer
, vol.73
, pp. 1324-1331
-
-
Iino, H.1
Fukayama, M.2
Maeda, Y.3
-
115
-
-
0031780224
-
Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
-
Martinez-lopez E, Abad A, Font A, et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998; 114:1180-1187.
-
(1998)
Gastroenterology
, vol.114
, pp. 1180-1187
-
-
Martinez-Lopez, E.1
Abad, A.2
Font, A.3
-
116
-
-
0028057398
-
High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer
-
Khine K, Smith DR, Goh HS, et al. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer 1994; 73:28-35.
-
(1994)
Cancer
, vol.73
, pp. 28-35
-
-
Khine, K.1
Smith, D.R.2
Goh, H.S.3
-
117
-
-
0035117307
-
Methylation of O6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability
-
Whitehall VL, Walsh MD, Young J, et al. Methylation of O6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001; 61:827-830.
-
(2001)
Cancer Res.
, vol.61
, pp. 827-830
-
-
Whitehall, V.L.1
Walsh, M.D.2
Young, J.3
-
118
-
-
0035874892
-
Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis
-
Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001; 61:4689-4692.
-
(2001)
Cancer Res.
, vol.61
, pp. 4689-4692
-
-
Esteller, M.1
Risques, R.A.2
Toyota, M.3
-
119
-
-
0242610375
-
Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict non-recurrence after chemotherapy in colorectal cancer cases
-
Nagasaka T, Sharp GB, Notohara K, et al. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict non-recurrence after chemotherapy in colorectal cancer cases. Clin Cancer Res 2003; 9:5306-5312.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 5306-5312
-
-
Nagasaka, T.1
Sharp, G.B.2
Notohara, K.3
|